From Name:
From Email:
To Name:
To Email:

Optional Message:

Co-testing may detect invasive cervical cancer better than HPV-only screening

from Cancer Therapy Advisor

Not only may co-testing help prevent more cases of invasive cervical cancer compared with screening for only human papillomavirus, but it also may lower overall health care costs. The clinical-economic modeling analysis was presented in poster form at the International Society for Pharmacoeconomics and Outcomes Research 18th Annual European Congress in Milan. Co-testing, which uses both an mRNA-based HPV and a liquid-based Papanicolaou test in combination, provides “the benefit of better detection, more saved lives, and not only is it not cost adverse, but it's actually cost beneficial,” the study's lead author, Juan Felix, M.D., told Cancer Therapy Advisor. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063